Over the past five years, Aaron Frey’s office has secured more than $260 million from pharmaceutical companies accused of “supercharging” the opioid epidemic.
Over the past five years, Aaron Frey’s office has secured more than $260 million from pharmaceutical companies accused of “supercharging” the opioid epidemic.
